Biotechnology develops precision antibiotics by harnessing the unique properties of phages.
BioPhoundry has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
BioPhoundry's investors include Creator Fund.
BioPhoundry is headquartered in Chapel Hill, United States.
Biotechnology develops precision antibiotics by harnessing the unique properties of phages.
BioPhoundry is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioPhoundry — Funding & Investors." VCBacked, January 29, 2025, https://www.vcbacked.co/company/biophoundry. Accessed August 13, 2026.
VCBacked. (2025). BioPhoundry — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biophoundry
{{cite web |title=BioPhoundry — Funding & Investors |url=https://www.vcbacked.co/company/biophoundry |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated